# US 2003/0211602 A1 · Isolation of mesenchymal stem cells and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0211602 A1
- Document ID: US20030211602A1
- Status: Published application
- Kind: A1
- Application number: 10/258,076
- Filed: 2003-03-04
- Published: 2003-11-13
- Earliest claimed: 2003-03-04
- Inventors: Anthony Atala
- Web page: https://patentgrep.com/patent/US20030211602A1

## CPC

- C12N 5/0654: {Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth}
- C12N 5/0668: {Mesenchymal stem cells from other natural sources}
- C12N 5/0653: {Adipocytes; Adipose tissue}
- C12N 5/0655: {Chondrocytes; Cartilage}
- A61F 2/02: Prostheses implantable into the body
- A61K 35/12: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
- C12N 2500/42: Organic phosphate, e.g. beta glycerophosphate
- C12N 2500/44: Thiols, e.g. mercaptoethanol
- C12N 2501/01: Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
- C12N 2501/02: Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
- C12N 2501/235: Leukemia inhibitory factor [LIF]
- C12N 2501/33: Insulin
- C12N 2501/39: Steroid hormones
- C12N 2509/00: Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides a method of isolating mesenchymal stem cells from postnatal human tissue such as postnatal human foreskin tissue. The present invention additionally provides a method of differentiating the isolated mesenchymal stem cells into various lineages, such as osteogenic, adipogenic, and chondrogenic lineages.

## Claims

### Claim 1

A method for obtaining human mesenchymal stem cells, the method comprising:
(a) providing a specimen of human connective tissue;
(b) holding the specimen in a sterile environment for at least 2 days at about 4C;
(c) isolating a dermal layer from the specimen;
(d) contacting the dermal layer with collagenase to provide a collagenase cell suspension;
(e) collecting supernatant from the collagenase cell suspension;
(f) centrifuging the supernatant to obtain a cell product;
(g) culturing the cell product under conditions to promote cell growth; and
(h) isolating mesenchymal stem cells from the culture.

### Claim 2 (depends on 1)

The method of claim 1, wherein the specimen is held in a sterile environment for 3-6 days.

### Claim 3 (depends on 1)

The method of claim 1, wherein the collagenase is collagenase I.

### Claim 4 (depends on 1)

The method of claim 1, wherein the human connective tissue is obtained from a human skin.

### Claim 5 (depends on 4)

The method of claim 4, wherein the human skin is foreskin.

### Claim 6 (depends on 1)

A human mesenchymal stem cell produced by the method of claim 1.

### Claim 7

A method for obtaining osteoblasts, the method comprising:
(a) providing a specimen of human connective tissue;
(b) holding the specimen in a sterile environment for at least 2 days at about 4 C.;
(c) isolating a dermal layer from the tissue;
(d) contacting the dermal layer with collagenase to provide a collagenase cell suspension;
(e) collecting supernatant from the collagenase cell suspension;
(f) centrifuging the supernatant to obtain a cell product; and (g) culturing the cell product under conditions to promote cell growth in contact with dexamethasone, beta-glycerophosphate and ascorbic acid-2-phosphate in amounts sufficient to induce human mesenchymal stem cells to undergo osteogenic differentiation.

### Claim 8

A method for obtaining adipocytes, the method comprising:
(a) providing a specimen of human connective tissue;
(b) holding the specimen in a sterile environment for at least 2 days at about 4 C.;
(c) isolating a dermal layer from the tissue;
(d) contacting the dermal layer with collagenase to provide a collagenase cell suspension;
(e) collecting supernatant from the collagenase cell suspension;
(f) centrifuging the supernatant to obtain a cell product; and
(g) culturing the cell product under conditions to promote cell growth in contact with dexamethasone, 3-isobutyl-1-methylxanthine, insulin, and indomethacin in an amount sufficient to induce human mesenchymal stem cells to undergo adipogenic differentiation.

### Claim 9

A method for obtaining chondrocytes, the method comprising:
(a) providing a specimen of human connective tissue;
(b) holding the specimen in a sterile environment for at least 2 days at about 4 C.;
(c) isolating a dermal layer from the tissue;
(d) contacting the dermal layer with collagenase to provide a collagenase cell suspension;
(e) collecting supernatant from the collagenase cell suspension;
(f) centrifuging the supernatant to obtain a cell product; and
(g) culturing the cell product under conditions to promote cell growth in contact with in contact with L-glutamine, MEM nonessential amino acids, 2-mercaptoethanol, dexamethasone, ascorbic acid-2-phosphate, and transforming growth factor 3 in an amount sufficient to induce human mesenchymal stem cells to undergo chondrogenic differentiation.
